A Randomized Phase 3 Open Label Study of Nivolumab Versus Bevacizumab and Multiple Phase 1 Safety Cohorts of Nivolumab or Nivolumab in Combination With Ipilimumab Across Different Lines of Glioblastoma
收藏DataCite Commons2026-01-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012711/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to compare the efficacy and safety of nivolumab administered alone versus bevacizumab in patients diagnosed with recurrent glioblastoma (a type of brain cancer, also known as GBM), and to evaluate the safety and tolerability of nivolumab administered alone or in combination with ipilimumab in patients with different lines of GBM therapy.
提供机构：
Vivli
创建时间：
2026-01-29
